ClinicalTrials.gov
public full text
Public Domain
Statins for Treatment of Primary Intracerebral Hemorrhage
The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)#1475055
- Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)#1307347
- Recombinant Factor VIIa in Acute Intracerebral Haemorrhage#891145
- C-reactive protein as a universal prognosticator in hemorrhagic stroke: a meta-analysis of intracerebral and aneurysmal subarachnoid hemorrhage.#672199
- The Role of Statins in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage#862840
Record · ID 1483581
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive